Staying hydrated is essential, along with light physical activity to promote digestion
Table 14: Results at Week 26 in a Trial Comparing TRESIBA to Sitagliptin in Adult Patients with Type 2 Diabetes Mellitus on OADs* Safety Outcomes Trial DEVOTE (NCT01959529) Cardiovascular Outcomes Trial Of TRESIBA Administered Once Daily Between Dinner And Bedtime In Combination With Standard Of Care In Subjects With Type 2 Diabetes And Atherosclerotic Cardiovascular Disease DEVOTE was a multi center, multi national, randomized, double blinded, active controlled, treat to target, event driven trial
Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
30-Day Supply (10 mL Vial)
Recent and anticipated novel drug approvals (3Q 2024 through 2Q 2025)
However, if it is used at very high doses over long periods, it can cause nerve damage (neuropathy)